ADAMTS9 is an IL-1 and TNF-inducible gene that appears to Demircan et al. 3 be more responsive to these pro-inflammatory cytokines than other aggrecanase genes.
Introduction
Articular cartilage is a highly specialized tissue that covers the bony surface in the synovial joints, allowing smooth lubrication and providing resistance to joint forces.
Cartilage matrix is synthesized and maintained by chondrocytes, and some of its constituents are the collagens II, IX, and XI, aggrecan, perlecan, COMP and others.
Aggrecan, a large aggregating proteoglycan, forms a macromolecular complex with hyaluronan and link protein. It swells within the interstices of the collagen framework and provides compressibility to cartilage (1, 2) .
Proteolytic degradation of articular cartilage is a key feature of arthritic joint destruction. The loss of aggrecan is considered to be a critical early event of cartilage destruction, occurring initially at the joint surface and progressing to the deeper zones. This step is followed by degradation of collagen fibrils and mechanical failure of the tissue (2) . The degradation of cartilage is mediated by a number of different proteases, including neutral endopeptidases of the metalloproteinase superfamily of enzymes.
Members of two metalloproteinase families, matrix metalloproteinase (MMP) and ADAMTS, have been implicated in cartilage matrix destruction (1) .
The ADAMTS (A disintegrin-like and metalloproteinase domain (reprolysin type) with thrombospondin type 1 motifs) family contains 19 individual gene products Demircan et al. 5 (3). Certain members of the ADAMTS family (ADAMTS1, ADAMTS4, ADAMTS5, ADAMTS8, ADAMTS9 and ADAMTS15) are called 'aggrecanases', and they can proteolytically process aggrecan within the interglobular domain separating its globular G1 and G2 of domains at a specific Glu 373 -Ala 374 bond (3) (4) (5) or at one or more sites within the more C-terminal glycosaminoglycan-bearing region (6) . Proteolytic liberation of the GAG-bearing regions reduces the load bearing properties of articular cartilage and may accompany or initiate a series of cellular responses that culminate in loss of joint cartilage. These proteases are believed to be active both in inflammatory arthritis and osteoarthritis.
Aggrecanase activity was first detected in bovine articular cartilage treated with IL-1 , but it is also enhanced by TNF-or retinoic acid (7, 8) . These data support the hypothesis that aggrecanases are active early in the disease process of arthritis, or in acute inflammatory episodes. However, the exact enzyme(s) responsible for cartilage aggrecan degradation both during active inflammation and as arthritis progresses are still unclear (9) . ADAMTS4 (aggrecanase-1), ADAMTS5 (aggrecanase-2) and subsequently, ADAMTS1, were the first proteases to which significant aggrecanase activity was attributed (4-6), although their specific importance in the context of arthritis is not yet fully established. Like ADAMTS4 and ADAMTS1, ADAMTS9,
Demircan et al. 6 and more recently ADAMTS8 and ADAMTS15 were shown to be aggrecanases (10) (11) (12) .
ADAMTS9 was expressed in OA in gene profiling studies (9, 13) . These experimental studies, observations from phylogeny of the ADAMTS proteases (3, 11) and absence of aggrecanase activity in numerous other ADAMTS proteases suggests that the enzymes examined in this study include the complete set of ADAMTS aggrecanases. To further investigate the significance of each of these, it would be important to study their expression and cytokine induction in chondrocytes.
Since normal articular cartilage is relatively acellular and difficult to obtain, we have instead used in these studies, OUMS-27, a recently established cell line with chondrocytic properties (14) . The effects of two major proinflammatory cytokines, IL-1 and TNF-, were investigated to ask how and which aggrecanase may play a role in inflammatory disease of cartilage
MATERIALS AND METHODS

Reagents
Recombinant human IL-1 and TNF-were purchased from R&D Systems Institute of Biomatrix, Tokyo, Japan). HSF are cultured as previously described (15) .
Generation of ADAMTS9 antibody
A synthetic peptide CQHPFQNEDYRPRSASPSRTH derived from the human ADAMTS9 amino acid sequence (13) 
Cytokine stimulation and protein kinase inhibitor assay
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All cells were first incubated in 4 ml of medium containing 10 % FBS. After 72 hr, the medium was changed to serum-free DMEM and the cells were incubated for another 24 hr. The cells were then exposed to various concentrations of IL-1 (10 to 100 ng/ml) and/or TNF-(5 to 50 ng/ml) in phosphate buffered saline (PBS), or PBS containing 0.1 % BSA as a control (n=4 each) following the protocol previously reported (16, 17) .
For kinase assays, cells were cultured on 60-mm dishes and serum-starved for 24 hr before stimulation. OUMS-27 cells were pretreated with 10-100 µM PD 98059, a specific inhibitor of p44/42 kinase, or 5-50 µM SB 203580, a specific inhibitor of p38 kinase, or DMSO alone (as a vehicle control) for 30 min and subsequently incubated with IL-1 (10 ng/ml).
RNA preparation and reverse transcription -polymerase chain reaction (RT-PCR)
Following stimulation, the cells were washed once with PBS and total RNA was extracted using TRIzol according to the manufacturer's instructions. 
Northern blot analysis
Northern blot analysis was performed as previously reported (19, 20) . Total Hybridization was carried out at 65°C overnight in Church buffer. The membrane Demircan et al. 12 was washed and then exposed to X-ray film (Kodak, Tokyo, Japan) with an intensifying screen. The radiolabeled bands were densitometrically quantified using a BAS image analyzing system (Fuji Film, Tokyo, Japan).
Protein extraction
Cells were incubated with or without cytokines in the medium as previously reported (22, 23) . After stimulation, the cells were washed once with PBS and then scraped from the culture dish. Cell pellets were solubilized in 400 µl of cell lysis buffer (Sigma) with a complete protease inhibitor cocktail (Sigma). For phosphorylation analysis, cells were washed with PBS and lysed in buffer containing 1 mM Na 3 VO 4 , 1 mM PMSF, 1 mM Na-F and complete protease inhibitor cocktail. After incubation in a rotator at 4 °C for 15 min, the samples were centrifuged and, the supernatants were collected. The protein concentration of the cell extracts was determined by using a protein assay kit (Bio-Rad, Hercules, CA, USA).
Western blot analysis
Cell lysates (15 µg of total protein/lane) were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using a 4-12 % gradient gel and then transferred onto nitrocellulose membranes (Advantech, Tokyo, Japan).
Demircan et al. 13 Membranes were blocked with 5 % skim milk and 0.05 % Triton X-100 in PBS (PBS-T), and then incubated with primary antibody in PBS-T for overnight.
Membranes were washed with PBS-T and then incubated with the appropriate HRP-conjugated secondary antibody diluted in blocking buffer. Immunoreactive proteins were detected using the enhanced chemiluminescence system (Amersham Pharmacia Biotech). To examine the regulation of ADAMTS9 protein expression by IL-1 , chondrosarcoma cells were incubated with medium in either the presence or absence of IL-1 (10 ng/ml). Protein expression in cell lysates was determined by
Western blot analysis.
Statistical analysis
Data are expressed as the mean value ±SD. Statistical comparisons of means were performed by analysis of variance (ANOVA) followed by paired-Student t-test.
A P-value of <0.05 was considered statistically significant.
RESULTS
The expression of cartilage specific ECM genes and ADAMTS genes in OUMS-27 cells
Demircan et al. 14 Initial experiments were performed to determine the mRNA expression of cartilage-specific proteoglycan (i.e., aggrecan) and other ECM genes in cultured OUMS-27 cells by RT-PCR. The cDNAs were prepared from unstimulated cultured OUMS-27 cells and amplified with specific primers for aggrecan, COL2A1, COL9A1 or -actin (Table I ). The PCR products were separated by electrophoresis on an agarose gel and specific bands corresponding to each gene product (COL2A1, 621bp; COL9A1, 159bp; aggrecan, 501bp;) were observed ( Figure 1A ). (Fig. 1C) .
Time course of aggrecanase expression after IL-1 stimulation
OUMS-27 cells were cultured in the presence of IL-1 (10 ng/ml), and total RNA was extracted at 3, 6, 12, 24, and 48 hr. The relative levels of individual aggrecanase gene mRNA expression were determined by quantitative real-time RT-PCR and compared with those of unstimulated cells (n=3 independent experiments). The polygonal-to-round chondrocytic shape was maintained in OUMS-27 cells during the stimulation ( Fig. 2A) .
As shown in Fig. 2B , ADAMTS1 mRNA expression was not increased, but rather decreased, by IL1-stimulation. IL1-increased the aggrecanase-1 (ADAMTS4) mRNA expression level; the increase was first noted at 6 hr, and it reached a maximum at 12 hr, following which it declined. The aggrecanase-2 (ADAMTS5) mRNA expression level also reached a peak at 12 hr and decreased at 48 hr.
The ADAMTS9 mRNA expression levels peaked at 6 hr and then gradually decreased.
ADAMTS9 was increased 13.3-fold compared at 6 hr with that of unstimulated cells.
ANOVA revealed that this elevation was significant (p<0.01). ADAMTS8 was not expressed in unstimulated OUMS-27 cells (Fig. 1C) or IL-1 -stimulated OUMS-27 cells (data not shown).
Demircan et al. 16 We then examined whether ADAMTS9 is induced in articular chondrocytes by IL-1 stimulation. The rounded polygonal shape of chondrocytes was maintained in monolayer culture during the stimulation (data not shown). As shown in Figure 2C , ADAMTS9 was significantly induced by IL-1 in chondrocytes with its peak at 6 hr.
The induction of ADAMTS9 mRNA expression by IL-1 in chondrocytes occurred in a similar time-dependent manner as OUMS-27 cells.
ADAMTS9 expression in OUMS-27 cells
Because ADAMTS9 was the aggrecanase gene most highly expressed without stimulation and most highly inducible by IL1-in OUMS-27 cells, we further characterized mRNA expressions of ADAMTS9 as well as ADAMTS4 and ADAMTS5 by Northern blot analysis. OUMS-27 cells were stimulated with IL1-(10 ng/ml) for 1, 3, 6, 12, 24, 48, and 72 hr and compared with unstimulated controls (n=3, respectively).
ADAMTS9 mRNA expression was first noted at 3 hr, and then further increased and reached a maximum at 6 hr, which was similar to that of human articular chondrocytes.
ADAMTS9 then decreased toward the baseline level (Fig. 3A, top) . The expression level of ADAMTS4 was very low and the bands were not detected by Northern blot analysis (data not shown). The positive band for ADAMTS5 was faintly detectable at 6 hr and 12 hr and expression levels were much weaker than ADAMTS9 (Fig. 3A, middle). We next examined the ADAMTS9 protein production in IL-1 stimulated OUMS-27 cells. Protein was extracted from cells with or without IL-1 stimulation (n=4, respectively) and Western blot analysis was performed using anti-ADAMTS9 polyclonal antibody. A strong band of around 180-200 kDa, which likely represents an active form of ADAMTS9, was clearly observed as expected (Fig. 3B) . We were not able to detect ADAMTS9 protein in the OUMS-27 cell culture medium suggesting the secreted enzyme may be cell-anchored as previously described.
Cytokine induction of ADAMTS9 gene expression in OUMS-27 cells is dose-dependent
Next, the dose response of ADAMTS9 mRNA to IL-1 and TNF-stimulation was examined. OUMS-27 cells were cultured in the presence of IL-1 (0 -100 ng/ml) or TNF-(0 -50 ng/ml) (n=3, respectively). IL-1 caused dose-dependent induction of ADAMTS9 mRNA (Fig. 3C) . TNF-alone induced ADAMTS9 mRNA expression as well, as previously reported in retinal pigment epithelium cells (25) , while TNF-did not show a linear dose-dependent induction of ADAMTS9 in OUMS-27 cells (Fig.   3D ).
Synergistic induction of ADAMTS9 mRNA expression in chondrosarcoma cells by the combination of IL1-and TNF-
Synergistic induction of ADAMTS was examined in chondrosarcoma cells
treated with the combination of IL-1 (10ng/ml) and TNF-(10ng/ml) at the 6 hr time point (Fig. 4A) . ADAMTS9 mRNA expression was markedly upregulated 33-fold by the combination of IL-1 and TNF-at 6 hr.
We also compared the induction of ADAMTS9 gene by the stimulation with IL-1 between chondrocytes and fibroblasts ( Fig. 4B) . ADAMTS9 was induced both in the chondrocytes and HSF cells.
Interestingly, the augmentation of the expression level of ADAMTS9 mRNA in chondrocytes was greater than that of HSF cells. Furthermore, the induction pattern of ADAMTS9 by IL-1 and/or TNF-was different between these two cell lines. That is, in chondrocytes, IL-1 augmented the expression level of ADAMTS9 mRNA more than TNF-, which was opposite in the case of HSF cells, and the synergistic effect of combination of IL-1 and TNF-was greater in chondrocytes than HSF cells (Fig. 4B ).
In contrast, ADAMTS4 mRNA expression appeared to be only moderately upregulated by IL-1 and TNF-and no induction of mRNA expression for ADAMTS5 was observed at 6 hr (data not shown).
IL-1 stimulates phosphorylation of MAPKs in OUMS-27 cells
In chondrocytes, the activation of the signaling pathways of mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinase (ERK) and Demircan et al. 19 p38, by IL-1 stimulation was reported (26, 27) . SB203580, a specific inhibitor p38, increased the phosphorylation of p38 by 10 min, and this increase was terminated by 60 min (Fig. 5A) . Phosphorylation of p44/42 peaked at 10 min and then, declined to the control level at 30 min. (Fig. 6A) . (Fig. 6B) . PD98059 also caused the attenuation Demircan et al. 20 of ADAMTS9 gene induction (Fig. 6C ).
DISCUSSION
In this study, we sought to identify which ADAMTS-aggrecanases were responsive to cytokine induction representative of some of the complex inflammatory cascade of arthritis. We showed that ADAMTSs were differentially regulated and In conclusion, our results showed that ADAMTS9 gene expression is strongly induced by cytokines in OUMS-27 cells as well as chondrocytes, suggesting its role in inflammatory arthritides. Future studies will address whether the induced secretion Demircan et al. 24 plays a major role in degradation of aggrecan or other secreted cartilage molecules. mRNA expression levels were compared with that of the unstimulated control.
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Relative expression levels of ADAMTS9 mRNA were determined by quantitative real-time RT-PCR. 
